Research ArticleAccepted Article
The development and evaluation of a personalized training in shared decision making skills for rheumatologists
S. Mahmood, J.M.W. Hazes, P. Veldt, P. van Riel, R. Landewé, H.J. Bernelot Moens and A. Pasma
The Journal of Rheumatology April 2019, jrheum.180780; DOI: https://doi.org/10.3899/jrheum.180780
S. Mahmood
From the Amsterdam Rheumatology and Immunology Center, Amsterdam, the Netherlands; Erasmus Medical Center, department of Rheumatology, Rotterdam, the Netherlands; Reinier de Graaf Gasthuis, department of Rheumatology, Delft, the Netherlands; Radboud University Medical Center, Radboud Insititute for Health Sciences, IQ Healthcare, Nijmegen, the Netherlands; Ziekenhuis Groep Twente, department of Rheumatology, Almelo, the Netherlands. Financial support for the study was provided by Pfizer bv. Address correspondence to Sehrash Mahmood, Bsc, Amsterdam Rheumatology and immunology Center, De Boelelaan 1117, 1081 HV the Netherlands, room 3A56. E-mail: s.mahmood@vumc.nl
J.M.W. Hazes
From the Amsterdam Rheumatology and Immunology Center, Amsterdam, the Netherlands; Erasmus Medical Center, department of Rheumatology, Rotterdam, the Netherlands; Reinier de Graaf Gasthuis, department of Rheumatology, Delft, the Netherlands; Radboud University Medical Center, Radboud Insititute for Health Sciences, IQ Healthcare, Nijmegen, the Netherlands; Ziekenhuis Groep Twente, department of Rheumatology, Almelo, the Netherlands. Financial support for the study was provided by Pfizer bv. Address correspondence to Sehrash Mahmood, Bsc, Amsterdam Rheumatology and immunology Center, De Boelelaan 1117, 1081 HV the Netherlands, room 3A56. E-mail: s.mahmood@vumc.nl
P. Veldt
From the Amsterdam Rheumatology and Immunology Center, Amsterdam, the Netherlands; Erasmus Medical Center, department of Rheumatology, Rotterdam, the Netherlands; Reinier de Graaf Gasthuis, department of Rheumatology, Delft, the Netherlands; Radboud University Medical Center, Radboud Insititute for Health Sciences, IQ Healthcare, Nijmegen, the Netherlands; Ziekenhuis Groep Twente, department of Rheumatology, Almelo, the Netherlands. Financial support for the study was provided by Pfizer bv. Address correspondence to Sehrash Mahmood, Bsc, Amsterdam Rheumatology and immunology Center, De Boelelaan 1117, 1081 HV the Netherlands, room 3A56. E-mail: s.mahmood@vumc.nl
P. van Riel
From the Amsterdam Rheumatology and Immunology Center, Amsterdam, the Netherlands; Erasmus Medical Center, department of Rheumatology, Rotterdam, the Netherlands; Reinier de Graaf Gasthuis, department of Rheumatology, Delft, the Netherlands; Radboud University Medical Center, Radboud Insititute for Health Sciences, IQ Healthcare, Nijmegen, the Netherlands; Ziekenhuis Groep Twente, department of Rheumatology, Almelo, the Netherlands. Financial support for the study was provided by Pfizer bv. Address correspondence to Sehrash Mahmood, Bsc, Amsterdam Rheumatology and immunology Center, De Boelelaan 1117, 1081 HV the Netherlands, room 3A56. E-mail: s.mahmood@vumc.nl
R. Landewé
From the Amsterdam Rheumatology and Immunology Center, Amsterdam, the Netherlands; Erasmus Medical Center, department of Rheumatology, Rotterdam, the Netherlands; Reinier de Graaf Gasthuis, department of Rheumatology, Delft, the Netherlands; Radboud University Medical Center, Radboud Insititute for Health Sciences, IQ Healthcare, Nijmegen, the Netherlands; Ziekenhuis Groep Twente, department of Rheumatology, Almelo, the Netherlands. Financial support for the study was provided by Pfizer bv. Address correspondence to Sehrash Mahmood, Bsc, Amsterdam Rheumatology and immunology Center, De Boelelaan 1117, 1081 HV the Netherlands, room 3A56. E-mail: s.mahmood@vumc.nl
H.J. Bernelot Moens
From the Amsterdam Rheumatology and Immunology Center, Amsterdam, the Netherlands; Erasmus Medical Center, department of Rheumatology, Rotterdam, the Netherlands; Reinier de Graaf Gasthuis, department of Rheumatology, Delft, the Netherlands; Radboud University Medical Center, Radboud Insititute for Health Sciences, IQ Healthcare, Nijmegen, the Netherlands; Ziekenhuis Groep Twente, department of Rheumatology, Almelo, the Netherlands. Financial support for the study was provided by Pfizer bv. Address correspondence to Sehrash Mahmood, Bsc, Amsterdam Rheumatology and immunology Center, De Boelelaan 1117, 1081 HV the Netherlands, room 3A56. E-mail: s.mahmood@vumc.nl
A. Pasma
From the Amsterdam Rheumatology and Immunology Center, Amsterdam, the Netherlands; Erasmus Medical Center, department of Rheumatology, Rotterdam, the Netherlands; Reinier de Graaf Gasthuis, department of Rheumatology, Delft, the Netherlands; Radboud University Medical Center, Radboud Insititute for Health Sciences, IQ Healthcare, Nijmegen, the Netherlands; Ziekenhuis Groep Twente, department of Rheumatology, Almelo, the Netherlands. Financial support for the study was provided by Pfizer bv. Address correspondence to Sehrash Mahmood, Bsc, Amsterdam Rheumatology and immunology Center, De Boelelaan 1117, 1081 HV the Netherlands, room 3A56. E-mail: s.mahmood@vumc.nl
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
The development and evaluation of a personalized training in shared decision making skills for rheumatologists
S. Mahmood, J.M.W. Hazes, P. Veldt, P. van Riel, R. Landewé, H.J. Bernelot Moens, A. Pasma
The Journal of Rheumatology Apr 2019, jrheum.180780; DOI: 10.3899/jrheum.180780
Accepted manuscript
The development and evaluation of a personalized training in shared decision making skills for rheumatologists
S. Mahmood, J.M.W. Hazes, P. Veldt, P. van Riel, R. Landewé, H.J. Bernelot Moens, A. Pasma
The Journal of Rheumatology Apr 2019, jrheum.180780; DOI: 10.3899/jrheum.180780